Bioptik Technology

Bioptik Technology Net Debt per Share

The Net Debt per Share of Bioptik Technology (4161.TWO) as of Nov 1, 2026 is 1.86 TWD. In the previous year, Net Debt per Share was 2.21 TWD — a change of -15.79% (lower).

Net Debt per Share

1.86TWD

YoY

-15.79%

Last updated:

Net Debt per Share of Bioptik Technology is 2025 1.86 TWD. Net Debt per Share of Bioptik Technology was 2024 2.21 TWD. It decreases by -15.79% lower compared to the previous year.

The Bioptik Technology Net Debt per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt per Share
Date
Net Debt per Share
Jan 1, 2018
5.20 TWD
Jan 1, 2019
4.96 TWD
Jan 1, 2020
3.86 TWD
Jan 1, 2021
5.70 TWD
Jan 1, 2022
5.52 TWD
Jan 1, 2023
2.16 TWD
Jan 1, 2024
2.21 TWD
Jan 1, 2025
1.86 TWD
The Bioptik Technology Net Debt per Share history
YEARNet Debt per ShareYoY
1.86TWD-15.79%
2.21TWD+2.19%
2.16TWD-60.90%
5.52TWD-3.17%
5.70TWD+47.75%
3.86TWD-22.13%
4.96TWD-4.60%
5.20TWD-4.40%
5.43TWD-221.42%
-4.48TWD-19.28%
-5.54TWD+56.31%
-3.55TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bioptik Technology Stock analysis

What does Bioptik Technology do? Bioptik Technology, Inc. generates revenue through the sale of hyaluronic acid-based skincare products and medical diagnostic equipment. The company sells multifunctional blood sugar, cholesterol, uric acid, and heme detectors under the Easy Mate and Easy Touch brands, along with testing paper products for these parameters. Its cosmetic line, distributed under ACUREAL, includes toning lotions, essences, facial masks, and face cleaning products. Domestic and international markets are the primary sales channels for both product categories. The firm targets healthcare providers and consumers seeking at-home medical monitoring solutions through its Easy Mate and Easy Touch devices. ACUREAL skincare products appeal to customers interested in biological and medical cosmetics for daily skincare routines. Bioptik Technology focuses on the domestic market and overseas markets for product distribution, ensuring broad accessibility across different regions. Easy Mate and Easy Touch are the key medical equipment brands, while ACUREAL represents the cosmetic segment. The company's product portfolio combines medical diagnostics with skincare, serving two distinct consumer segments: health-conscious individuals monitoring vital metrics and users seeking specialized skincare solutions. This dual approach allows Bioptik Technology to leverage its research and development capabilities across both medical and cosmetic applications. Bioptik Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bioptik Technology stock

Net Debt per Share of Bioptik Technology is 1.86 TWD in 2025.

Net Debt per Share of Bioptik Technology changed from 2.21 TWD to 1.86 TWD, representing a -15.79% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt per Share Bioptik Technology since 2006 – with annual values, charts, and detailed analysis.

Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Bioptik Technology

All Key Metrics — Bioptik Technology